|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.90 EUR | -0.86% |
|
-1.82% | +18.58% |
| Jul. 09 | FTSE 100 held back by AstraZeneca trial setback | AN |
| Jul. 09 | WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook | AN |
Company Valuation: Coca-Cola Europacific Partners plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,392 | 23,518 | 27,644 | 34,572 | 34,806 | 41,046 | - | - |
| Change | - | 5.03% | 17.54% | 25.06% | 0.68% | 17.93% | - | - |
| Enterprise Value (EV) 1 | 34,067 | 33,724 | 37,101 | 44,244 | 44,629 | 50,840 | 50,724 | 50,705 |
| Change | - | -1.01% | 10.01% | 19.25% | 0.87% | 13.92% | -0.23% | -0.04% |
| P/E | 22.5x | 15.6x | 16.6x | 24.4x | 18.2x | 21.4x | 19.5x | 18.2x |
| PBR | 3.19x | 3.16x | 3.46x | 4.07x | 4.44x | 5.05x | 4.75x | 4.47x |
| PEG | - | 0.3x | 1.6x | -1.6x | 0.5x | 11.23x | 2.1x | 2.47x |
| Capitalization / Revenue | 1.63x | 1.36x | 1.51x | 1.69x | 1.67x | 1.91x | 1.84x | 1.77x |
| EV / Revenue | 2.48x | 1.95x | 2.03x | 2.16x | 2.14x | 2.36x | 2.27x | 2.19x |
| EV / EBITDA | 12.7x | 11.6x | 11.9x | 12.6x | 12.1x | 12.9x | 12.2x | 11.5x |
| EV / EBIT | 18.1x | 19x | 15.6x | 16.6x | 15.9x | 17.1x | 16x | 15x |
| EV / FCF | 19.3x | 13.9x | 17.4x | 19.5x | 20.3x | 26.6x | 24.7x | 24.5x |
| FCF Yield | 5.19% | 7.21% | 5.75% | 5.13% | 4.94% | 3.75% | 4.05% | 4.08% |
| Dividend per Share 2 | 1.4 | 1.68 | 1.84 | 1.97 | 2.04 | 2.214 | 2.384 | 2.574 |
| Rate of return | 2.85% | 3.27% | 3.06% | 2.63% | 2.63% | 2.39% | 2.57% | 2.78% |
| EPS 2 | 2.18 | 3.29 | 3.63 | 3.08 | 4.26 | 4.341 | 4.744 | 5.094 |
| Distribution rate | 64.2% | 51.1% | 50.7% | 64% | 47.9% | 51% | 50.3% | 50.5% |
| Net sales 1 | 13,763 | 17,320 | 18,302 | 20,438 | 20,901 | 21,523 | 22,331 | 23,172 |
| EBITDA 1 | 2,688 | 2,910 | 3,127 | 3,524 | 3,700 | 3,929 | 4,156 | 4,395 |
| EBIT 1 | 1,886 | 1,772 | 2,373 | 2,663 | 2,808 | 2,965 | 3,170 | 3,388 |
| Net income 1 | 998 | 1,508 | 1,669 | 1,418 | 1,942 | 1,958 | 2,109 | 2,244 |
| Net Debt 1 | 11,675 | 10,206 | 9,457 | 9,672 | 9,823 | 9,795 | 9,679 | 9,660 |
| Reference price 2 | 49.08 | 51.45 | 60.20 | 75.00 | 77.50 | 92.70 | 92.70 | 92.70 |
| Nbr of stocks (in thousands) | 456,235 | 457,106 | 459,201 | 460,960 | 449,106 | 442,778 | - | - |
| Announcement Date | 2/16/22 | 2/16/23 | 2/23/24 | 2/14/25 | 2/17/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 21.35x | 2.36x | 12.94x | 2.39% | 46.97B | ||
| 16.67x | 2.26x | 11.5x | 4.31% | 185B | ||
| 15.39x | 1.4x | 7.02x | 4.19% | 21.72B | ||
| 29.52x | 0.83x | 10.45x | 1.69% | 4.26B | ||
| 14.37x | 1.9x | 8.55x | 4.82% | 1.57B | ||
| 13.63x | 1.44x | 8.13x | 3.21% | 946M | ||
| Average | 18.49x | 1.70x | 9.76x | 3.44% | 43.39B | |
| Weighted average by Cap. | 17.59x | 2.18x | 11.34x | 3.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CCEP Stock
- Valuation Coca-Cola Europacific Partners plc
Select your edition
All financial news and data tailored to specific country editions
















